[Form 4] GE HealthCare Technologies Inc. Insider Trading Activity

Rhea-AI Filing Summary

Philip Rackliffe, an officer (CEO, AVS) of GE HealthCare Technologies Inc. (GEHC), reported multiple share dispositions on 09/01/2025 related to the vesting of restricted stock units. The Form 4 shows shares were withheld to satisfy tax withholding obligations at a price of $73.73 per share. The transactions list dispositions of 165, 134, 204 and 1,388 shares. Following the final reported withholding the filing shows 15,582 shares beneficially owned directly by the reporting person. The Form 4 was signed by counsel as attorney-in-fact on 09/03/2025.

Insights

Financial Analyst

TL;DR: Routine tax-withholding on RSU vesting; de minimis for company valuation.

The filing documents share withholding to cover taxes when restricted stock units vested. The transactions are disposals, not open-market sales for cash-raising, and occurred at a stated price of $73.73 per share. The aggregate withheld amount is reported across four entries and results in a reported direct holding of 15,582 shares after the final transaction. For investors, this is a routine compensation-related event with limited direct impact on GEHC's capital structure or operations.

Corporate Governance Expert

TL;DR: Compliance filing shows standard insider reporting and tax-withholding; no governance red flags.

The Form 4 indicates timely disclosure of beneficial ownership changes by an officer, and the explanatory note clarifies these were tax-withholding actions tied to RSU vesting. The form is signed by an attorney-in-fact, which is an accepted practice. There is no indication of atypical trading, planned disposition, or related-party concerns in the text provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rackliffe Philip

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, AVS

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	09/01/2025		F		165(1)	D	$73.73	17,308	D
Common Stock, par value $0.01 per share	09/01/2025		F		134(1)	D	$73.73	17,174	D
Common Stock, par value $0.01 per share	09/01/2025		F		204(1)	D	$73.73	16,970	D
Common Stock, par value $0.01 per share	09/01/2025		F		1,388(1)	D	$73.73	15,582	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed for GEHC on 09/03/2025 report?

The Form 4 reports that Philip Rackliffe had shares withheld to satisfy tax withholding upon RSU vesting, with transactions dated 09/01/2025.

How many shares were withheld and at what price in the GEHC Form 4?

The filing lists dispositions of 165, 134, 204 and 1,388 shares at a price of $73.73 per share.

What were Philip Rackliffe's reported direct holdings after the transactions?

Following the reported transactions the filing shows 15,582 shares beneficially owned directly.

Was the Form 4 filing for GEHC an individual or joint filing?

The form indicates it was filed by one reporting person (individual filing).

Why were the shares disposed according to the Form 4 explanation?

The explanation states the shares were withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units.